StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) SEC filings

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70+0.07 (+1.40%)

Close on Nov 17, 2026Market cap $7.37MP/E –Yield –

SEC filings

19 of Curanex Pharmaceuticals's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 13, 2026SEC EDGAR
Current report8-KSep 14, 2026Oct 19, 2026SEC EDGAR
Current report8-KSep 3, 2026Sep 4, 2026SEC EDGAR
Current report8-KAug 14, 2026Aug 17, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 14, 2026SEC EDGAR
Current report8-KMay 14, 2026May 14, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KMay 5, 2026May 7, 2026SEC EDGAR
Current report8-KApr 2, 2026Apr 2, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 30, 2026SEC EDGAR
Current report8-KMar 1, 2026Mar 6, 2026SEC EDGAR
Current report8-KDec 31, 2025Jan 5, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 17, 2025SEC EDGAR
Current report8-KNov 5, 2025Nov 6, 2025SEC EDGAR
Current report8-KSep 23, 2025Sep 29, 2025SEC EDGAR
Current report8-KSep 12, 2025Sep 12, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Sep 9, 2025SEC EDGAR
Current report8-KAug 27, 2025Aug 27, 2025SEC EDGAR
Current report8-KAug 25, 2025Aug 26, 2025SEC EDGAR

See a number that looks wrong?